BRASH syndrome, the vicious cycle: A case report

Authors

  • Twinkle Saini Philadelphia College of Osteopathic Medicine, Philadelphia, PA, USA
  • Jacky Reny Thomas Jefferson University, Philadelphia, PA, USA
  • Hussam Al Hennawi Department of Internal Medicine, Jefferson Abington Hospital, Abington, PA, USA.
  • Andrew Cox Department of Internal Medicine, Jefferson Abington Hospital, Abington, PA, USA.
  • Chaitra Janga Department of Internal Medicine, Jefferson Abington Hospital, Abington, PA, USA.
  • Danila DeLiana Department of Internal Medicine, Jefferson Abington Hospital, Abington, PA, USA.
  • James McCaffrey Department of Internal Medicine, Jefferson Abington Hospital, Abington, PA, USA.

DOI:

https://doi.org/10.21542/gcsp.2023.2

Abstract

First described in 2016, BRASH syndrome is an underreported clinical entity characterized by bradycardia, renal dysfunction, atrioventricular nodal blockade (AVNB), shock, and hyperkalemia. The recognition of BRASH syndrome as a clinical entity is crucial for early and effective management. Patients with BRASH syndrome present with symptomatic bradycardia that is resistant to treatment with standard agents such as atropine. In this report, we present the case of a 67-year-old male patient who presented with symptomatic bradycardia with an ultimate diagnosis of BRASH syndrome. We also shed light on predisposing factors and challenges encountered during the management of affected patients.

Downloads

Published

2023-02-06

Issue

Vol. 2023 No. 1 (2023)

Section

Images in cardiology

License

Copyright (c) 2023 Twinkle Saini, Jacky Reny, Hussam Al Hennawi, Andrew Cox, Chaitra Janga, Danila DeLiana, James McCaffrey

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

This is an open access article distributed under the terms of the Creative Commons Attribution license CC BY 4.0, which permits unrestricted use, distribution and reproduction in any medium, provided the original work is properly cited.